AAAAAA

   
Results: 1-8 |
Results: 8
Survival analysis in familial ovarian cancer, a case control study
Authors: Zweemer, RP Verheijen, RHM Coebergh, JWW Jacobs, IJ van Diest, PJ Gille, JJP Skates, S Menko, FH Ten Kate, LP Kenemans, P
Citation: Rp. Zweemer et al., Survival analysis in familial ovarian cancer, a case control study, EUR J OB GY, 98(2), 2001, pp. 219-223
Tubal ligation and risk of ovarian cancer
Authors: Piek, JMJ van Diest, PJ Zweemer, RP Kenemans, P Verheijen, RHM
Citation: Jmj. Piek et al., Tubal ligation and risk of ovarian cancer, LANCET, 358(9284), 2001, pp. 844-844
Comparative genomic hybridization of microdissected familial ovarian carcinoma: Two deleted regions on chromosome 15q not previously identified in sporadic ovarian carcinoma
Authors: Zweemer, RP Ryan, A Snijders, AM Hermsen, MAJA Meijer, GA Beller, U Menko, FH Jacobs, IJ Baak, JPA Verheijen, RHM Kenemans, P van Diest, PJ
Citation: Rp. Zweemer et al., Comparative genomic hybridization of microdissected familial ovarian carcinoma: Two deleted regions on chromosome 15q not previously identified in sporadic ovarian carcinoma, LAB INV, 81(10), 2001, pp. 1363-1370
Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer
Authors: Piek, JMJ van Diest, PJ Zweemer, RP Jansen, JW Poort-Keesom, RJJ Menko, FH Gille, JJP Jongsma, APM Pals, G Kenemans, P Verheijen, RHM
Citation: Jmj. Piek et al., Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer, J PATHOLOGY, 195(4), 2001, pp. 451-456
Molecular evidence linking primary cancer of the Fallopian tube to BRCA1 germline mutations
Authors: Zweemer, RP van Diest, PJ Verheijen, RHM Ryan, A Gille, JJP Sijmons, RH Jacobs, IJ Menko, FH Kenemans, P
Citation: Rp. Zweemer et al., Molecular evidence linking primary cancer of the Fallopian tube to BRCA1 germline mutations, GYNECOL ONC, 76(1), 2000, pp. 45-50
Familial ovarian cancer
Authors: Zweemer, RP Jacobs, IJ
Citation: Rp. Zweemer et Ij. Jacobs, Familial ovarian cancer, METH MOL M, 39, 2000, pp. 13-24
Differences between hereditary and sporadic ovarian cancer
Authors: Zweemer, RP Verheijen, RHM Menko, FH Gille, JJP van Diest, PJ Coebergh, JW Shaw, PA Jacobs, IJ Kenemans, P
Citation: Rp. Zweemer et al., Differences between hereditary and sporadic ovarian cancer, EUR J OB GY, 82(2), 1999, pp. 151-153
Accumulation of p53 protein is frequent in ovarian cancers associated withBRCA1 and BRCA2 germline mutations
Authors: Zweemer, RP Shaw, PA Verheijen, RMH Ryan, A Berchuck, A Ponder, BAJ Risch, H McLaughlin, JR Narod, SA Menko, FH Kenemans, P Jacobs, IJ
Citation: Rp. Zweemer et al., Accumulation of p53 protein is frequent in ovarian cancers associated withBRCA1 and BRCA2 germline mutations, J CLIN PATH, 52(5), 1999, pp. 372-375
Risultati: 1-8 |